Silverback Therapeutics, Inc. (22)

Browse by Contract Category

Contracts

Amendment No. 1 to Cell Line License Agreement, by and between the registrant and WuXi Biologics (Hong Kong) Limited, dated January 12, 2021 (Filed With SEC on March 29, 2021)
Description of Registrants Common Stock (Filed With SEC on March 29, 2021)
Non-Employee Director Compensation Policy (Filed With SEC on November 30, 2020)
Master Laboratory Services Agreement, by and between the registrant and Q Squared Solutions LLC, dated May 25, 2020 (Filed With SEC on November 10, 2020)
Lease, by and between the registrant and BMR-500 Fairview Avenue LLC, dated June 8, 2016 (Filed With SEC on November 10, 2020)
Letter Agreement, by and between the registrant and Jonathan Piazza, dated November 3, 2020 (Filed With SEC on November 10, 2020)
Silverback Therapeutics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on November 30, 2020)
Silverback Therapeutics, Inc. 2020 Equity Incentive Plan, and Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder (Filed With SEC on November 30, 2020)
Form of Common Stock Certificate of the registrant (Filed With SEC on November 30, 2020)
Form of Underwriting Agreement (Filed With SEC on November 30, 2020)
Cell Line License Agreement, by and between the registrant and WuXi Biologics (Hong Kong) Limited, dated October 11, 2019 (Filed With SEC on November 10, 2020)
Silverback Therapeutics, Inc. 2020 Change in Control and Severance Benefit Plan (Filed With SEC on November 10, 2020)
Loan and Security Agreement, by and between the registrant and Silicon Valley Bank, dated November 21, 2016, as amended (Filed With SEC on November 10, 2020)
Amended and Restated Investors Rights Agreement, by and between the registrant and certain of its stockholders, dated September 22, 2020 (Filed With SEC on November 10, 2020)
Warrant to purchase stock issued to Silicon Valley Bank, dated November 21, 2016 (Filed With SEC on November 10, 2020)
Letter Agreement, by and between the registrant and Naomi Hunder, M.D., dated December 22, 2018 (Filed With SEC on November 10, 2020)
Letter Agreement, by and between the registrant and Valerie Odegard, Ph.D., dated July 23, 2016 (Filed With SEC on November 10, 2020)
Letter Agreement, by and between the registrant and Laura Shawver, Ph.D., dated March 6, 2020, as amended (Filed With SEC on November 10, 2020)
Silverback Therapeutics, Inc. 2016 Equity Incentive Plan, as amended, and Forms of Option Agreement, Notice of Exercise, Notice of Early Exercise, Restricted Stock Grant Notice... (Filed With SEC on November 10, 2020)
Form of Indemnity Agreement, by and between the registrant and its directors and officers (Filed With SEC on November 10, 2020)
Warrant to purchase stock issued to Silicon Valley Bank, dated December 22, 2017 (Filed With SEC on November 10, 2020)
Master Services Agreement, by and between the registrant and CE3, Inc., dated January 21, 2020 (Filed With SEC on November 10, 2020)